Researchers discover new therapeutic approach for neuroblastoma

Neuroblastomas are tumors of the nervous system. They can form in many places in the body and are the most common cause of cancer-related deaths in young children.

Galenica continues to grow in the 2023 financial year – Biotech Investments

Galenica AG / Key word(s): Annual Results 12-March-2024 / 06:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

March 13, 2024

23andMe wins FDA clearance to test for expanded set of BRCA cancer risk variants

Dive Brief: The U.S. Food and Drug Administration cleared 23andMe on Thursday to report another 41 BRCA1 and BRCA2 gene variants in its cancer risk test.

September 5, 2023

Dementia Risk Linked With Cumulative Heartburn Med Use, Analysis Suggests

Cumulative use of proton pump inhibitors (PPIs) — drugs used to help control acid reflux and other gastrointestinal disorders — upped the risk of dementia,

August 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.